Description General description Selective inhibitor of DAG lipase activity in canine platelets (IC50 = 4 nM) and in a variety of mammalian cells. Also inhibits glucose- and carbachol-induced insulin release from intact islets. An inhibitor of Angiotensin II (Cat. No. 05-23-0101) and ATP-induced synthesis of 6-keto-prostaglandin F1α. Selective inhibitor of DAG lipase activity in canine platelets (IC50 = 4 nM) and in a variety of mammalian cells. Also inhibits glucose- and carbachol-induced insulin release from intact islets. An inhibitor of Angiotensin II and ATP-induced synthesis of 6-keto-prostaglandin F1α. Packaging 10 mg in Plastic ampoule Biochem/physiol Actions Cell permeable: no Primary Target DAG lipase Product does not compete with ATP. Reversible: no Target IC50: 4 nM against DAG lipase activity in canine platelets Warning Toxicity: Standard Handling (A) Reconstitution Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. Other Notes Shinoda, J., et al. 1997. Arterioscler. Thromb. Vasc. Biol. 17, 295. Shinoda, J., et al. 1997. Eur. J. Endocrinol. 136, 207. Konrad, R.J., et al. 1994. Biochemistry 33, 13284. Mason-Garcia, M., et al. 1992. Am. J. Physiol.262, C1197. Balsinde, J., et al. 1991. J. Biol. Chem.266, 15638.